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Julia A. Segre1
For two centuries, Koch’s postulates have set the gold standard for establishing the microbiological etiology of
infection and disease. Genomic sequencing now brings finer resolution to both bacterial strain variation and the
host genetic state that may predispose to disease. In this issue of the JID, Fitz-Gibbons and colleagues present
strain-based resolution of Propionibacterium acnes and its association with the common teenage malady acne
vulgaris. Here I examine how Koch’s postulates were envisioned and incorporate this finer resolution of both
host and microbial states.
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Developed in the 19th century, Robert
Koch’s postulates are the four criteria
designed to assess whether a microor-
ganism causes a disease (Falkow, 1988).
As originally stated, the four criteria are
as follows: (1) the microorganism must
be found in diseased but not in healthy
individuals; (2) the microorganism must
be cultured from the diseased indivi-
dual; (3) inoculation of a healthy indivi-
dual with the cultured microorganism
must recapitulate the disease; and finally
(4) the microorganism must be reisolated
from the inoculated, diseased individual
and must match the original microorgan-
ism. Koch’s postulates have been criti-
cally important in establishing the criteria
whereby the scientific community agrees
that a microorganism causes a disease.
Even Koch had to modify or bend the
strictest interpretation of the first postu-
late. Koch discovered asymptomatic
carriers of Vibrio cholera and Salmo-
nella typhi, yielding the important
distinction between asymptomatic
clinical colonization and infection. Thus
the field of inquiry into the intricate
host–pathogen relationship was born.
Now, genomics adds greater resolu-
tion to Koch’s postulates in the context
of common disorders which are not clas-
sical infectious disease. Acne vulgaris is
a prevalent chronic inflammatory dis-
ease of the pilo-sebaceous unit charac-
terized by follicular plugging (Williams
et al., 2012). The underlying factors
associated with acne lesions are as
follows: (1) increased sebum produc-
tion; (2) inflammation; (3) altered folli-
cular keratinization; and (4) overgrowth
with Propionibacterium acnes. However,
over the years, it has been difficult to
ascertain which of these four factors
initiates, promotes, or is merely asso-
ciated with the disease state. In particu-
lar, to what extent does P. acnes
contribute to the development of acne?
The mainstay therapies of inflammatory
acne include topical and systemic
antibiotics, suggesting a microbial con-
tribution. However, these common
therapies often show incomplete res-
ponse, and recurrence is frequent
(Leyden, 2001). In addition, systemic
acne treatments sometimes possess
untolerated side effects, suggesting that
more targeted therapeutics would be
beneficial.
P. acnes is a commensal Gram-
positive anaerobe that is part of the
microbial community of most sebaceous
sites on normal healthy adults (Grice
et al., 2009). However, does overgrowth
of P. acnes trigger skin inflammation?
In this issue of the JID, Craft and Li and
colleagues examine the strain-level
diversity of P. acnes of acne patients
and healthy individuals by sequencing
both direct clinical samples and full
genomes of P. acnes (Fitz-Gibbon et al.,
2013). Their rationale for pursuing
this species-level P. acnes resolution is
based on classic epidemiologic studies
stating that certain strains of micro-
organisms are associated with different
outcomes, e.g., methicillin-resistant
Staphylococcus aureus-USA300 or
Escherichia coli O157.
Fitz-Gibbon et al. (2013) compared
P. acnes strain diversity by direct
sequencing of the signature bacterial
16S ribosomal RNA (rRNA) genes from
B50 acne patients and 50 normal
controls. Skin microcomedone samples
were obtained from the pilosebaceous
units (pores) of the nose with Biore
strips. Acne affectation was graded
with the Global Acne Severity Scale,
ranging from 0 (unaffected) to 5 (most
severe), for subjects’ face and nose. The
acne cohort’s severity ranged from 1 to
5 with an average of 2.1 and noses
ranged from 0 to 2 with an average of
0.3. The acne cohort and the normal
cohort had an average age of 22.2 and
29.6 years, respectively. Treatment
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information was collected from three-
quarters of the total cohort, with 9
reporting current treatment and 18
total reporting a history of treatment
with antibiotics and/or retinoids.
Biore strips were placed individually
in lysis buffer from which DNA was
directly isolated. From each subject,
B400 16S rRNA clones were sequen-
ced, with 87% matching P. acnes. No
difference was observed in the relative
abundance of P. acnes between acne
and normal cohorts. Fitz-Gibbon et al.
(2013) assigned each 16S rRNA clone to
a strain type based on single nucleotide
variants and calculated the prevalence
of each P. acnes strain in acne and
normal cohorts. Of the 10 most
common strain types, the authors found
that three were evenly distributed
between the two cohorts, six were
more often found in acne patients, and
one was associated with normal skin.
The full-length 16S rRNA gene is
B1,500 bp, and many of these strain
types differed from each other by only
1 bp, and thus the authors next explored
whether these small changes represent
lineages at the full genome level. A total
of 66 P. acnes genomes, representing
multiple isolates from many of the major
strain types, were fully sequenced.
Isolates from the same strain clustered
together in the phylogenetic tree based
on the full genome sequence, suggesting
that 16S rRNA sequences do reflect
the evolutionary history of P. acnes
lineages. The genomes of acne-enriched
strains selectively harbor a plasmid and
two chromosomal regions that contain
genes possibly involved in virulence,
adhesion to epithelial tissues, or induc-
tion of human immune response.
Two letters to the editor by Alexeyev
and Zouboulis (2013), and Eady and
Layton (2013) raise issues about the
study design utilized by the authors’
P. acnes research article. Both letters
raise the concern that the nose is not
an appropriate sampling site, as it is
typically unaffected. Although in the
acne cohort all had facial acne, only
one-third had acne on the nose. Human
studies have often found changes in
gene expression or skin properties
(such as barrier function) in unaffected
skin sites. However, the authors might
have gained greater specificity if acne
lesions had been specifically sampled.
These letters also raise issue with the
technique deployed in this study, given
that P. acnes resides deep within the
anaerobic part of the hair follicle. Craft
and Li’s response (2013) provides further
elucidation as to the typical sample
obtained with a Biore strip and how
the follicles were plucked off the strip
with micro-forceps. These samples are
thus considered ‘pre-lesional’ by Craft
and Li (2013).
Eady and Layton raise further con-
cerns with the vague clinical history of
the subjects in this study, who are on
average in their mid-twenties, or one
decade past the typical age of acne
onset. The oldest control subject is 80
years old, with 8 control subjects aged
42 years or older. For almost 20% of the
total subjects, medication treatment his-
tories were not given, but no matter
since it is difficult for patients to accu-
rately report antimicrobial usage in the
last year, let alone one decade earlier.
Although a physician or trained study
coordinator questioned every subject, a
previous history of acne does not appear
to be an exclusion for normal subjects.
Current and previous medication use is
an unexplored confounder for these
studies.
While Alexeyev and Zouboulis’
(2013) and Eady and Layton’s (2013)
letters raise issues with study design,
they are also intrigued by the potential
to generate new testable hypotheses
linking acne vulgaris to specific strains
of P. acnes, which ultimately might lead
to more targeted therapies. Identifying
genes specifically encoded by more
pathogenic P. acnes is an exciting new
possibility from these genomic studies. It
would be interesting to initiate a long-
itudinal study to examine the proportion
of different ribotypes as teenagers pro-
gress through puberty and either do or
do not develop acne. Samples could be
obtained from affected and unaffected
pores and analyses stratified for medica-
tion usage. This longitudinal survey
could also examine whether common
therapies target specific strain types and
whether efficacy is related to the initial
community of P. acnes strains. How-
ever, even this level of resolution will
only begin to satisfy Koch’s postulates.
The most challenging part will be mov-
ing from association to causality.
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